The U.S. Supreme Court agreed to consider a pair of whistleblower-initiated False Claims Act cases accusing two pharmacy operators of billing Medicare and Medicaid programs for prescription drugs at artificially high rates while charging non-governmentally insured customers lesser prices for those same drugs.
The U.S. Court of Appeals for the Fifth Circuit ruled that the CFPB's independent funding process which runs through the Federal Reserve rather than through congressional appropriations violates the Constitution's separation of powers clause.
The District Court for the Middle District of Tennessee granted a motion to dismiss a tax refund suit relating to cryptocurrency staking rewards on mootness grounds after the IRS issued the refund.
The U.S. District Court for the Central District of California authorized the IRS to serve a "John Doe" summons on a California-based cryptocurrency prime dealer. The IRS is seeking information about as-yet unidentified U.S. taxpayers who conducted at least $20,000 in cryptocurrency transactions with the dealer.
A jury returned a rare verdict in a "qui tam" False Claims Act matter, finding a pharmaceutical company liable for $61 million in damages arising out of purported misconduct involving the Medicaid Drug Rebate Program.